How To Prevent and Control Pediatric Influenza

Presenter(s):

Overview:

Children, especially those with chronic medical conditions or neurologic and neurodevelopmental disorders, are at higher risk of influenza-associated complications. Influenza prevention and control strategies in this at-risk population should include annual seasonal influenza immunization for all people 6 months and older and prompt antiviral treatment when influenza disease is indicated. During this COCA call, subject matter experts will discuss strategies that providers can use to improve influenza prevention and control in children at highest risk.

Objectives

• Describe strategies to assist in preparing for the 2015-2016 influenza season
• Identify gaps and opportunities to improve influenza prevention and control for children with chronic medical conditions
• Discuss the importance of promptly identifying children clinically presumed to have influenza disease for rapid antiviral treatment, when indicated, to reduce morbidity and mortality
• Identify ways to improve preparedness for infectious disease outbreaks within the office practice

Call Materials

• Slides: View Now
• Transcript: Read Now
• Audio: Listen Now
• Webcast: Watch Now

Call Format

• Audio conference call on 10/01/15: 2:00 - 3:00 PM
• Web-on-demand training after 3:00 PM on 10/01/15
• Materials: PowerPoint slide set

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Non-physicians will receive a certificate of participation.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 1.0 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.0. CDC provider number GA0082.

CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 1.0 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-15-156-L04-P and enduring 0387-0000-15-156-H04-P course category.

This program is knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.2 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.